Chinedu A Ugwu, Oluwasina Alao, Oluwagboadurami G John, Blossom Akinnawo, Israel Ajayi, Ooreofe Odebode, Ifeoluwa Bejide, Allan Campbell, Julian Campbell, Jolly A Adole, Idowu B Olawoye, Kazeem Akano, Johnson Okolie, Philomena Eromon, Peter Olaitan, Ajibola Olagunoye, Ibukun Adebayo, Victor Adebayo, Elizabeth Babalola, Omowumi Abioye, Nnennaya Ajayi, Emeka Ogah, Kingsley Ukwaja, Sylvanus Okoro, Ogbonnaya Oje, Ojide Chiedozie Kingsley, Matthew Eke, Venatius Onyia, Olivia Achonduh-Atijegbe, Friday Elechi Ewah, Mary Obasi, Violet Igwe, Olufemi Ayodeji, Abejegah Chukwuyem, Sampson Owhin, Nicholas Oyejide, Sylvester Abah, Winifred Ingbian, Moyosoore Osoba, Ahmed Alebiosu, Angalee Nadesalingam, Ernest T Aguinam, George Carnell, Nina Krause, Andrew Chan, Charlotte George, Rebecca Kinsley, Paul Tonks, Nigel Temperton, Jonathan Heeney, Christian Happi
INTRODUCTION: One of the unexpected outcomes of the COVID-19 pandemic was the relatively low levels of morbidity and mortality in Africa compared to the rest of the world. Nigeria, Africa's most populous nation, accounted for less than 0.01% of the global COVID-19 fatalities. The factors responsible for Nigeria's relatively low loss of life due to COVID-19 are unknown. Also, the correlates of protective immunity to SARS-CoV-2 and the impact of pre-existing immunity on the outcome of the COVID-19 pandemic in Africa are yet to be elucidated...
2024: Frontiers in Immunology